Live Breaking News & Updates on வெளிநாட்டு பரிமாற்றம் முதலீடு துறை

Stay updated with breaking news from வெளிநாட்டு பரிமாற்றம் முதலீடு துறை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Beximco Pharmaceut Announcements | Beximco Pharmaceut: Proposed acquisition of stake in Sanofi Bangladesh


 
 
Beximco Pharmaceuticals Limited ( Beximco Pharma or the Company , or the Group ; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces it has entered into a binding commitment with Sanofi group regarding the acquisition of a majority stake in Sanofi Bangladesh Limited ( Sanofi Bangladesh ) for a base-price consideration of circa £35.5 million, to be adjusted as set out below (the
Proposed
Transaction ). The
Proposed
Transaction is subject to approval by the Foreign Exchange Investment Department of Bangladesh Bank and completing the Share Purchase Agreement.
 
 
·
Expands the Company s product offering and reinforces its strategy to diversify into new and expanding specialty therapy areas ....

United States , United Kingdom , Mohammad Ali Nawaz , Mark Brady Andrew , Vadim Alexandre Abigail Wayne , Foster Mitchell , Sanofi Sa , Beximco Pharma , Sm Rabbur Reza , Sanofi Bangladesh Limited , Beximco Pharmaceuticals , Beximco Pharmaceuticals Limited Pharma , Foreign Exchange Investment Department Of Bangladesh Bank , Advisory Partners Limited Nominated Adviser , Ministry Of Industries , Sp Angel Corporate Finance , Bangladesh Chemical Industries Corporation , Nuvista Pharma , Sanofi Bangladesh , Market Abuse Regulation , English Law , Pharmaceuticals Limited , Proposed Transaction , Foreign Exchange Investment Department , Bangladesh Bank , Share Purchase ,

Beximco Pharma to acquire a majority stake in Sanofi Bangladesh Limited | Bangladesh Sangbad Sangstha (BSS)


Beximco Pharma to acquire a majority stake in Sanofi Bangladesh Limited
355
DHAKA, Jan 21, 2021 (BSS) – Beximco Pharmaceuticals Limited today announces that it has signed agreement (binding commitment) to acquire a majority shareholding (54.6 percent) in Sanofi Bangladesh Limited (Sanofi Bangladesh), a concern of French pharmaceutical giant Sanofi with global sales in excess of Euro 36 billion in 2019.
Sanofi Group currently holds 54.6 percent shares in the paid-up capital of Sanofi Bangladesh, said a press release.
The remaining shares are held by the government of Bangladesh represented by the Ministry of Industries (approx. 25.36 percent) and Bangladesh Chemical Industries Corporations (approx.19.96 percent).
The Proposed Acquisition is subject to Bangladesh government clearance (including necessary approval of the Transaction by the Foreign Exchange Investment Department and Bangladesh Bank) and completion of a definitive Sale and Purchase Agreement. It i ....

Beximco Pharma , Sanofi Bangladesh Limited , Bangladesh Chemical Industries Corporations , Beximco Pharmaceuticals , Foreign Exchange Investment Department , Sanofi Group , Bangladesh Bank , Sanofi Bangladesh Ltd , Ministry Of Industries , Sanofi Bangladesh , Beximco Pharmaceuticals Limited , Proposed Acquisition , சனோஃபி பங்களாதேஷ் வரையறுக்கப்பட்டவை , பங்களாதேஷ் இரசாயன தொழில்கள் நிறுவனங்கள் , வெளிநாட்டு பரிமாற்றம் முதலீடு துறை , சனோஃபி குழு , பங்களாதேஷ் வங்கி , சனோஃபி பங்களாதேஷ் லிமிடெட் , அமைச்சகம் ஆஃப் தொழில்கள் , சனோஃபி பங்களாதேஷ் , ப்ரபோஸ்ட் கையகப்படுத்தல் ,